MENU
+Compare
SNSE
Stock ticker: NASDAQ
AS OF
Apr 1, 04:59 PM (EDT)
Price
$0.34
Change
-$0.05 (-12.82%)
Capitalization
12.78M

SNSE Sensei Biotherapeutics Forecast, Technical & Fundamental Analysis

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients... Show more

SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SNSE with price predictions
Mar 31, 2025

SNSE in upward trend: price may ascend as a result of having broken its lower Bollinger Band on March 31, 2025

SNSE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 34 cases where SNSE's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SNSE advanced for three days, in of 149 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SNSE as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SNSE turned negative on March 31, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .

SNSE moved below its 50-day moving average on March 31, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SNSE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SNSE entered a downward trend on March 20, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.279) is normal, around the industry mean (13.677). P/E Ratio (0.000) is within average values for comparable stocks, (64.969). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.870). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (255.565).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SNSE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SNSE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SNSE is expected to report earnings to fall 26.87% to -22 cents per share on May 13

Sensei Biotherapeutics SNSE Stock Earnings Reports
Q1'25
Est.
$-0.23
Q4'24
Missed
by $0.03
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.01
Q1'24
Missed
by $0.04
The last earnings report on March 28 showed earnings per share of -31 cents, missing the estimate of -28 cents. With 446.62K shares outstanding, the current market capitalization sits at 12.78M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1405 Research Boulevard
Phone
+1 240 243-8000
Employees
27
Web
https://www.senseibio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HFFG4.900.53
+12.13%
HF Foods Group
BLIN1.480.01
+0.68%
Bridgeline Digital
OSIS194.341.02
+0.53%
OSI Systems
ENFN11.150.05
+0.45%
Enfusion
EXPE168.10N/A
N/A
Expedia Group

SNSE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SNSE has been loosely correlated with VSTM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SNSE jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNSE
1D Price
Change %
SNSE100%
-22.49%
VSTM - SNSE
47%
Loosely correlated
-2.58%
ALZN - SNSE
40%
Loosely correlated
-10.54%
GRI - SNSE
37%
Loosely correlated
-26.71%
FATE - SNSE
36%
Loosely correlated
-6.97%
GOSS - SNSE
34%
Loosely correlated
-5.98%
More